Editorial draft — not for publication yet. Mirtazapine content needs clinical and legal review before publication. This page is general information and is not advice about an individual prescription.
In short
Miramind is a Bangladesh brand of mirtazapine made by Biopharma Limited; its manufacturer insert lists 7.5 mg and 15 mg tablets for depression. In the UK, mirtazapine is a prescription antidepressant indicated in product information for adult major depression. It can cause sleepiness, increased appetite and weight gain. Sedation does not make it a routine insomnia medicine, and anxiety treatment should be based on a clinical assessment and UK guidance.
Miramind UK product status
Biopharma Limited’s product insert identifies Miramind as mirtazapine USP 7.5 mg and 15 mg film-coated tablets in Bangladesh. NHS describes mirtazapine as prescription-only in the UK, and the emc lists UK mirtazapine products from multiple manufacturers. Those ingredient-level records do not authenticate an individual Miramind pack or establish UK authorisation or supply of that exact brand. Check the live MHRA Products database or ask a UK pharmacist about the exact product.
What does the manufacturer say about Miramind?
Biopharma’s Bangladesh insert lists Miramind (mirtazapine) for depression. UK product information indicates mirtazapine tablets for adult episodes of major depression. Anxiety and sleep symptoms may occur alongside depression, but those searches should not be confused with a product indication or a reason to self-start an overseas pack.
- Bangladesh product information identifies Miramind as mirtazapine in 7.5 mg and 15 mg film-coated tablets.
- UK product information indicates mirtazapine for episodes of major depression in adults; the medicine is prescription-only.
- NICE GAD guidance recommends an SSRI when medication is chosen; mirtazapine is not listed as a routine first-choice medicine for GAD alone.
- Mirtazapine can cause sleepiness and may be taken in the evening, but it is not indicated as a routine insomnia medicine in the selected UK product information.
- A UK listing for the generic ingredient does not verify the authorisation, contents or supply route of a particular Miramind pack.
The selected UK mirtazapine tablet SmPC indicates treatment of episodes of major depression in adults. The exact formulation and product leaflet should be checked for the medicine supplied.
NICE recommends shared decision-making for depression treatment. Its GAD medicine pathway recommends an SSRI when medication is chosen, then another SSRI or an SNRI if needed; individual specialist decisions may differ.
NHS says mirtazapine is prescription-only, usually starts to work after 1 or 2 weeks, and should not be stopped suddenly because withdrawal symptoms can occur.
How does it work?
Mirtazapine is a noradrenergic and specific serotonergic antidepressant. Product information says its precise antidepressant mechanism is not fully established, although it appears to increase noradrenergic and serotonergic activity through effects on particular receptors. It can also cause sleepiness; this side effect does not predict an individual antidepressant response.
Risks and possible effects
Common effects
NHS lists sleepiness, headache, dry mouth, increased appetite and weight gain, dizziness, nausea, vomiting and diarrhoea among common effects. Not everyone experiences them.
Seek prompt advice
Contact a healthcare professional for suicidal thoughts, unusually elevated mood, jaundice, or signs of infection such as fever, sore throat or mouth ulcers. Call 999 for suspected anaphylaxis or another life-threatening emergency.
Safety information
- Tell the prescriber about bipolar disorder or past mania, epilepsy, liver or kidney disease, heart conditions, diabetes, allergies, pregnancy or breastfeeding, and all medicines and supplements.
- Do not take mirtazapine with an MAOI. Ask a prescriber or pharmacist to check antidepressants, opioids, benzodiazepines, carbamazepine, St John’s wort and every other medicine.
- Avoid alcohol because it may increase drowsiness. Do not drive, cycle in traffic or use machinery if sleepy, dizzy or unable to concentrate.
- Do not stop suddenly. Contact the prescriber for an individual plan if you want to reduce or change treatment.
- Miramind is identified in Bangladesh product information. A brand name or foreign leaflet does not authenticate an overseas pack or establish its UK authorisation.
Miramind is a Bangladesh brand of mirtazapine
Biopharma Limited’s insert identifies Miramind as mirtazapine USP and lists film-coated 7.5 mg and 15 mg tablets. These are manufacturer details for the Bangladesh brand; they do not verify the identity or supply status of an individual pack.
In the UK, mirtazapine is a prescription-only antidepressant. The emc lists UK products containing the generic ingredient in several forms, but this does not confirm that Miramind itself is authorised for UK supply. Ask a pharmacist to check the exact brand, strength and manufacturer.
Depression, anxiety and sleep are different search intents
UK product information indicates mirtazapine for episodes of major depression in adults. NICE recommends an SSRI when medication is chosen for generalised anxiety disorder; mirtazapine is not the routine first-choice medicine in that pathway. A specialist may sometimes make an individual off-label decision, which should be explained and monitored.
Mirtazapine can cause sleepiness and is usually taken before bedtime, but sleepiness is an adverse effect, not proof that the medicine is a sleeping tablet. It is not indicated as routine insomnia treatment in the selected UK product information.
How long it takes, side effects and review
NHS says mirtazapine may start working after 1 or 2 weeks, but it can take longer to judge improvement. Sleepiness, increased appetite and weight gain are common topics to discuss. NICE recommends an early follow-up after starting antidepressant medication, with earlier review for some people at increased risk.
Do not change or stop the dose on your own. NHS advises gradual reduction with a prescriber because stopping suddenly can cause withdrawal symptoms. Seek urgent help for severe allergic symptoms, suicidal thoughts, possible mania, jaundice or signs of infection.
If you have a Miramind pack or need urgent advice
Check the active ingredient, strength, dosage form, manufacturer and country on the pack. Use the MHRA Products database or ask a UK pharmacist about current product status; an authorised mirtazapine product does not authenticate a different overseas brand.
For an overdose, NHS says to call 111 if more than prescribed was taken; call 999 for severe symptoms or difficulty waking. Keep the package or leaflet available for the clinician.
Frequently asked questions
What is the generic name of Miramind?
Miramind is a brand of mirtazapine, according to Biopharma Limited’s Bangladesh product insert.
What is Miramind used for?
Biopharma’s insert lists Miramind (mirtazapine) for depression. UK product information indicates mirtazapine for adult episodes of major depression.
Is Miramind available in the UK?
The Bangladesh manufacturer listing does not establish UK authorisation of the brand or any particular pack. Mirtazapine generic products are listed in UK medicine information; check the exact brand with the MHRA database or a pharmacist.
Can Miramind be used for anxiety?
Miramind contains mirtazapine. NICE’s routine GAD medicine pathway recommends an SSRI, then another SSRI or an SNRI if needed. A prescriber can discuss any individual off-label use.
Is Miramind a sleeping tablet?
No. Mirtazapine can cause sleepiness, but UK product information indicates it for adult depression rather than routine insomnia.
Can I stop mirtazapine suddenly?
No. NHS advises speaking with a doctor and reducing it gradually because withdrawal symptoms can occur.
Explore the detailed miramind (mirtazapine) guides
Each guide answers a different practical question. Advice is specific to mirtazapine and should be checked against your own product leaflet and prescription.
- What is Miramind? Mirtazapine brand, strengths and uses
- Is Miramind available in the UK? Brand and product status
- Miramind (mirtazapine) for depression: UK information
- Can Miramind or mirtazapine help with anxiety?
- Miramind for sleep: mirtazapine, drowsiness and insomnia
- How does mirtazapine work?
- How long does mirtazapine take to work?
- Miramind strengths and mirtazapine dosage explained
- Miramind side effects: sleepiness, appetite and weight gain
- Mirtazapine serious side effects: warning signs and help
- Mirtazapine interactions with alcohol and other medicines
- Mirtazapine warnings: who may need extra care?
- Mirtazapine in pregnancy and breastfeeding
- Stopping mirtazapine: withdrawal and safe review
- Can you drive while taking mirtazapine?
- Missed mirtazapine dose or overdose: what to do
- Mirtazapine vs SSRIs: differences, uses and questions to ask
Sources and review
This draft was checked against the sources below on 3 October 2026. It still requires clinical and legal review before publication.
- Biopharma Limited, Bangladesh: Miramind: manufacturer product insert (7.5 mg and 15 mg tablets)
- Biopharma Limited, Bangladesh: Miramind 7.5 mg tablet: manufacturer product page
- NHS: Mirtazapine: uses, taking it, side effects and safety
- electronic Medicines Compendium: Mirtazapine 15 mg tablets: Summary of Product Characteristics
- electronic Medicines Compendium: Mirtazapine 15 mg tablets: Patient Information Leaflet
- electronic Medicines Compendium: UK mirtazapine products and patient leaflets
- MHRA: MHRA Products: check UK medicine product records
- NICE: Depression in adults: treatment and management recommendations
- NICE: Generalised anxiety disorder and panic disorder in adults: recommendations
- NICE: Medicines associated with dependence or withdrawal symptoms: recommendations
- NHS: Poisoning: what to do and when to get urgent help
Editorial status: UK clinical and product-status review required before publication.